Sale!

ZFPM2 Gene Tetralogy of Fallot Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ZFPM2 Gene Tetralogy of Fallot Genetic Test is a specialized diagnostic tool used to identify mutations in the ZFPM2 gene, which have been linked to Tetralogy of Fallot (TOF), a complex congenital heart defect. This test is crucial for understanding the genetic underpinnings of TOF and can provide valuable information for affected families regarding the risk of recurrence in future pregnancies. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific genetic alterations associated with the condition. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the ZFPM2 gene. This genetic test is an important step towards personalized medicine, offering insights that can guide clinical decisions and management strategies for individuals with Tetralogy of Fallot.

Description

ZFPM2 Gene Tetralogy of Fallot Genetic Test

Test Name: ZFPM2 Gene Tetralogy of Fallot Genetic Test

Components: DNA Labs UAE offers the ZFPM2 Gene Tetralogy of Fallot Genetic Test at a cost of AED 4400.0

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information: Prior to undergoing the ZFPM2 Gene Tetralogy of Fallot Genetic Test, it is important to provide the clinical history of the patient. A Genetic Counselling session may also be conducted to draw a pedigree chart of family members affected with the ZFPM2 Gene Tetralogy of Fallot NGS Genetic DNA Test gene ZFPM2.

Test Details: The ZFPM2 gene codes for a protein called zinc finger protein, FOG family member 2. Mutations in this gene have been associated with Tetralogy of Fallot (TOF), a congenital heart defect characterized by four specific heart structure defects. These defects include a ventricular septal defect, pulmonary stenosis, right ventricular hypertrophy, and an overriding aorta. NGS (Next-Generation Sequencing) is a genetic testing technique used to analyze multiple genes or the entire genome simultaneously. In the case of TOF, NGS can identify mutations or variations in the ZFPM2 gene that may contribute to the development of the condition. This information aids in the diagnosis, prognosis, and management of TOF. It is important to note that genetic testing is typically performed alongside other diagnostic methods, such as imaging tests and clinical evaluations, to confirm the diagnosis of TOF. Genetic testing may also be recommended for family members to determine their risk of developing the condition.

Test Name	ZFPM2 Gene Tetralogy of Fallot Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cardiovascular Pneumology Disorders
Doctor	Cardiologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for ZFPM2 Gene Tetralogy of Fallot NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ZFPM2 Gene Tetralogy of Fallot NGS Genetic DNA Test gene ZFPM2
Test Details	ZFPM2 is a gene that codes for a protein called zinc finger protein, FOG family member 2. Mutations in this gene have been associated with a congenital heart defect called Tetralogy of Fallot (TOF). TOF is a complex heart condition characterized by four specific defects in the structure of the heart. These defects include a ventricular septal defect (a hole between the two lower chambers of the heart), pulmonary stenosis (narrowing of the pulmonary valve and artery), right ventricular hypertrophy (thickening of the right ventricle), and an overriding aorta (the aorta is shifted to the right and receives blood from both ventricles). NGS (Next-Generation Sequencing) is a genetic testing technique that allows for the simultaneous analysis of multiple genes or the entire genome. In the case of TOF, NGS can be used to identify mutations or variations in the ZFPM2 gene that may be responsible for the development of the condition. By analyzing the genetic information of an individual using NGS, doctors and geneticists can identify specific mutations or variations in the ZFPM2 gene that may contribute to the development of TOF. This information can help in the diagnosis, prognosis, and management of the condition. It is important to note that while genetic testing can provide valuable information, it is usually performed in conjunction with other diagnostic methods, such as imaging tests and clinical evaluations, to confirm the diagnosis of TOF. Additionally, genetic testing may also be recommended for family members of individuals with TOF to determine their risk of developing the condition.